- call +1-201-465-4211
- email sales@mrinsights.biz
Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.
Scope of the Report:
This report studies the Organ Transplantation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Organ Transplantation market by product type and applications/end industries.
Organs that have been successfully transplanted include the heart, kidneys, brain, liver, lungs, pancreas, intestine, and thymus. From year 2000 and forward, there has been approximately 2,200 lung transplants performed each year worldwide. From between 2000 and 2006, the median survival period for lung transplant patients has been 5-and-a-half years, meaning half the patients survived for a shorter time period and half survived for a longer period. In China, a kidney transplant operation runs for around $70,000, liver for $160,000, and heart for $120,000. Although these prices are still unattainable to the poor, compared to the fees of the United States, where a kidney transplant may demand $100,000, a liver $250,000, and a heart $860,000, Chinese prices have made China a major provider of organs and transplantation surgeries to other countries. In India, a kidney transplant operation runs for around as low as $5000.
The global Organ Transplantation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Organ Transplantation.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer
Sanofi
Veloxis Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Heart
Kidney
Liver
Lungs
Market Segment by Applications, can be divided into
Children
Adults
Senior Citizens
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Organ Transplantation Market Overview
1.1 Product Overview and Scope of Organ Transplantation
1.2 Classification of Organ Transplantation by Types
1.2.1 Global Organ Transplantation Revenue Comparison by Types (2017-2023)
1.2.2 Global Organ Transplantation Revenue Market Share by Types in 2017
1.2.3 Heart
1.2.4 Kidney
1.2.5 Liver
1.2.6 Lungs
1.3 Global Organ Transplantation Market by Application
1.3.1 Global Organ Transplantation Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Children
1.3.3 Adults
1.3.4 Senior Citizens
1.4 Global Organ Transplantation Market by Regions
1.4.1 Global Organ Transplantation Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Organ Transplantation Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Organ Transplantation Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Organ Transplantation Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Organ Transplantation Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Organ Transplantation Status and Prospect (2013-2023)
1.5 Global Market Size of Organ Transplantation (2013-2023)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Organ Transplantation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.2 Terumo
2.2.1 Business Overview
2.2.2 Organ Transplantation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Terumo Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Organ Transplantation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma
2.4.1 Business Overview
2.4.2 Organ Transplantation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.5 Preservation Solutions
2.5.1 Business Overview
2.5.2 Organ Transplantation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Preservation Solutions Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.6 Transmedic
2.6.1 Business Overview
2.6.2 Organ Transplantation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Transmedic Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Organ Transplantation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Organ Transplantation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.9 Veloxis Pharmaceuticals
2.9.1 Business Overview
2.9.2 Organ Transplantation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Veloxis Pharmaceuticals Organ Transplantation Revenue, Gross Margin and Market Share (2016-2017)
3 Global Organ Transplantation Market Competition, by Players
3.1 Global Organ Transplantation Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Organ Transplantation Players Market Share
3.2.2 Top 10 Organ Transplantation Players Market Share
3.3 Market Competition Trend
4 Global Organ Transplantation Market Size by Regions
4.1 Global Organ Transplantation Revenue and Market Share by Regions
4.2 North America Organ Transplantation Revenue and Growth Rate (2013-2018)
4.3 Europe Organ Transplantation Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Organ Transplantation Revenue and Growth Rate (2013-2018)
4.5 South America Organ Transplantation Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Organ Transplantation Revenue and Growth Rate (2013-2018)
5 North America Organ Transplantation Revenue by Countries
5.1 North America Organ Transplantation Revenue by Countries (2013-2018)
5.2 USA Organ Transplantation Revenue and Growth Rate (2013-2018)
5.3 Canada Organ Transplantation Revenue and Growth Rate (2013-2018)
5.4 Mexico Organ Transplantation Revenue and Growth Rate (2013-2018)
6 Europe Organ Transplantation Revenue by Countries
6.1 Europe Organ Transplantation Revenue by Countries (2013-2018)
6.2 Germany Organ Transplantation Revenue and Growth Rate (2013-2018)
6.3 UK Organ Transplantation Revenue and Growth Rate (2013-2018)
6.4 France Organ Transplantation Revenue and Growth Rate (2013-2018)
6.5 Russia Organ Transplantation Revenue and Growth Rate (2013-2018)
6.6 Italy Organ Transplantation Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Organ Transplantation Revenue by Countries
7.1 Asia-Pacific Organ Transplantation Revenue by Countries (2013-2018)
7.2 China Organ Transplantation Revenue and Growth Rate (2013-2018)
7.3 Japan Organ Transplantation Revenue and Growth Rate (2013-2018)
7.4 Korea Organ Transplantation Revenue and Growth Rate (2013-2018)
7.5 India Organ Transplantation Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Organ Transplantation Revenue and Growth Rate (2013-2018)
8 South America Organ Transplantation Revenue by Countries
8.1 South America Organ Transplantation Revenue by Countries (2013-2018)
8.2 Brazil Organ Transplantation Revenue and Growth Rate (2013-2018)
8.3 Argentina Organ Transplantation Revenue and Growth Rate (2013-2018)
8.4 Colombia Organ Transplantation Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Organ Transplantation by Countries
9.1 Middle East and Africa Organ Transplantation Revenue by Countries (2013-2018)
9.2 Saudi Arabia Organ Transplantation Revenue and Growth Rate (2013-2018)
9.3 UAE Organ Transplantation Revenue and Growth Rate (2013-2018)
9.4 Egypt Organ Transplantation Revenue and Growth Rate (2013-2018)
9.5 Nigeria Organ Transplantation Revenue and Growth Rate (2013-2018)
9.6 South Africa Organ Transplantation Revenue and Growth Rate (2013-2018)
10 Global Organ Transplantation Market Segment by Type
10.1 Global Organ Transplantation Revenue and Market Share by Type (2013-2018)
10.2 Global Organ Transplantation Market Forecast by Type (2018-2023)
10.3 Heart Revenue Growth Rate (2013-2023)
10.4 Kidney Revenue Growth Rate (2013-2023)
10.5 Liver Revenue Growth Rate (2013-2023)
10.6 Lungs Revenue Growth Rate (2013-2023)
11 Global Organ Transplantation Market Segment by Application
11.1 Global Organ Transplantation Revenue Market Share by Application (2013-2018)
11.2 Organ Transplantation Market Forecast by Application (2018-2023)
11.3 Children Revenue Growth (2013-2018)
11.4 Adults Revenue Growth (2013-2018)
11.5 Senior Citizens Revenue Growth (2013-2018)
12 Global Organ Transplantation Market Size Forecast (2018-2023)
12.1 Global Organ Transplantation Market Size Forecast (2018-2023)
12.2 Global Organ Transplantation Market Forecast by Regions (2018-2023)
12.3 North America Organ Transplantation Revenue Market Forecast (2018-2023)
12.4 Europe Organ Transplantation Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Organ Transplantation Revenue Market Forecast (2018-2023)
12.6 South America Organ Transplantation Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Organ Transplantation Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Organ Transplantation Picture
Table Product Specifications of Organ Transplantation
Table Global Organ Transplantation and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
